Opportunity for Evaluation of Pharmaceutical Products - Antiretroviral (HIV/AIDS), Antituberculosis and Antimalarial Medicines
10 March 2026
The Global Fund invites manufacturers of pharmaceutical products to submit an Expression of Interest (Eol) to have their products evaluated by the Expert Review Panel for pharmaceutical products (ERP). This evaluation will concern Antiretroviral (HIV/AIDS), Antituberculosis and Antimalarial medicines. Detailed information about the review process and submission requirements can be found on the Expert Review Panel page.
The deadline for submission is 4 May 2026.
Invitation to Manufacturers to Submit an Expression of Interest for Product Evaluation by the Global Fund Expert Review Panel for Pharmaceutical Products
download in English